(NP (NP (NN Purpose)) (: :) (S (VP (TO To) (VP (VB validate) (NP (ADJP (NP (DT the) (NN performance)) (PP (IN of) (NP (NP (DT a) (JJ commercially-available) (, ,) (JJ CE-certified) (JJ deep) (NN learning) (PRN (-LRB- -LRB-) (NNP DL) (-RRB- -RRB-)) (NN system)) (, ,) (NP (NNP RetCAD) (NN v.1.3.0)) (PRN (-LRB- -LRB-) (NP (NP (NNP Thirona)) (, ,) (NP (NP (NNP Nijmegen)) (, ,) (NP (DT The) (NNP Netherlands)))) (-RRB- -RRB-)))) (, ,))) (PP (IN for) (NP (NP (DT the) (JJ joint) (JJ automatic) (NN detection)) (PP (IN of) (NP (NP (NP (JJ diabetic) (NN retinopathy)) (PRN (-LRB- -LRB-) (NP (NNP DR)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ age-related) (JJ macular) (NN degeneration)) (PRN (-LRB- -LRB-) (NP (NNP AMD)) (-RRB- -RRB-))))) (PP (IN in) (NP (NN color) (NN fundus) (PRN (-LRB- -LRB-) (NNP CF) (-RRB- -RRB-)) (VBZ images))) (PP (IN on) (NP (NP (DT a) (NN dataset)) (PP (IN with) (NP (NP (JJ mixed) (NN presence)) (PP (IN of) (NP (NN eye) (NNS diseases)))))))))))) (. .))
(NP (NP (NNS Methods)) (: :) (S (NP (NP (NN Evaluation)) (PP (IN of) (NP (NP (JJ joint) (NN detection)) (PP (IN of) (NP (JJ referable) (NNP DR) (CC and) (NNP AMD)))))) (VP (VBD was) (VP (VBN performed) (PP (IN on) (NP (NP (DT a) (JJ DR-AMD) (NN dataset)) (PP (IN with) (NP (NP (CD 600) (NNS images)) (VP (VBN acquired) (PP (IN during) (NP (JJ routine) (JJ clinical) (NN practice)))))) (, ,) (VP (VBG containing) (NP (NP (ADJP (JJ referable) (CC and) (JJ non-referable)) (NNS cases)) (PP (IN of) (NP (DT both) (NNS diseases)))))))))) (. .))
(S (NP (DT Each) (NN image)) (VP (VBD was) (VP (VBN graded) (PP (IN for) (NP (NNP DR) (CC and) (NNP AMD))) (UCP (PP (PP (IN by) (NP (DT an) (JJ experienced) (NN ophthalmologist))) (S (VP (TO to) (VP (VB establish) (NP (NP (DT the) (NN reference) (NN standard)) (PRN (-LRB- -LRB-) (NP (NNP RS)) (-RRB- -RRB-))))))) (, ,) (CC and) (VP (PP (IN by) (NP (CD four) (JJ independent) (NNS observers))) (PP (IN for) (NP (NP (NN comparison)) (PP (IN with) (NP (JJ human) (NN performance))))))))) (. .))
(S (NP (NN Validation)) (VP (VBD was) (ADVP (RB furtherly)) (VP (VP (VBN assessed) (PP (IN on) (NP (NP (NNP Messidor)) (PRN (-LRB- -LRB-) (NP (CD 1200) (NNS images)) (-RRB- -RRB-)))) (PP (IN for) (NP (NP (JJ individual) (NN identification)) (PP (IN of) (NP (JJ referable) (NNP DR)))))) (, ,) (CC and) (VP (NP (NP (DT the) (JJ Age-Related) (NNP Eye) (NNP Disease) (NNP Study) (PRN (-LRB- -LRB-) (NNP AREDS) (-RRB- -RRB-)) (NN dataset)) (PRN (-LRB- -LRB-) (NP (CD 133821) (NNS images)) (-RRB- -RRB-))) (PP (IN for) (NP (JJ referable) (NNP AMD)))) (, ,) (PP (IN against) (NP (DT the) (JJ corresponding) (NNP RS))))) (. .))
(NP (NP (NNS Results)) (: :) (S (S (VP (VBG Regarding) (NP (NP (JJ joint) (NN validation)) (PP (IN on) (NP (DT the) (NNP DR-AMD) (NN dataset)))))) (, ,) (NP (DT the) (NN system)) (VP (VBD achieved) (NP (NP (DT an) (NN area)) (PP (IN under) (NP (NP (DT the) (NNP ROC) (NN curve)) (PRN (-LRB- -LRB-) (NP (NNP AUC)) (-RRB- -RRB-)))) (PP (IN of) (NP (CD 95.1) (NN %)))) (PP (IN for) (NP (NP (NN detection)) (PP (IN of) (NP (JJ referable) (NNP DR))))) (PRN (-LRB- -LRB-) (NP (NP (NNP SE=90.1) (NN %)) (, ,) (NP (NNP SP=90.6) (NN %))) (-RRB- -RRB-)))) (. .))
(S (PP (IN For) (NP (JJ referable) (NNP AMD))) (, ,) (NP (DT the) (NNP AUC)) (VP (VBD was) (NP (NP (CD 94.9) (NN %)) (PRN (-LRB- -LRB-) (NP (NP (NNP SE=91.8) (NN %)) (, ,) (NP (NNP SP=87.5) (NN %))) (-RRB- -RRB-)))) (. .))
(S (S (NP (NP (JJ Average) (JJ human) (NN performance)) (PP (IN for) (NP (NNP DR)))) (VP (VBD was) (NP (NP (NNP SE=61.5) (NN %)) (CC and) (NP (NNP SP=97.8) (NN %))))) (: ;) (S (PP (IN for) (NP (NNP AMD))) (, ,) (NP (NP (NNP SE=76.5) (NN %)) (CC and) (NP (NNP SP=96.1) (NN %)))) (. .))
(S (S (S (VP (VBG Regarding) (NP (NP (NN detection)) (PP (IN of) (NP (JJ referable) (NNP DR))) (PP (IN in) (NP (NNP Messidor)))))) (, ,) (NP (NNP AUC)) (VP (VBD was) (NP (NP (CD 97.5) (NN %)) (PRN (-LRB- -LRB-) (NP (NP (NNP SE=92.0) (NN %)) (, ,) (NP (NNP SP=92.1) (NN %))) (-RRB- -RRB-))))) (: ;) (S (PP (IN for) (NP (NP (JJ referable) (NNP AMD)) (PP (IN in) (NP (NNP AREDS))))) (, ,) (NP (NNP AUC)) (VP (VBD was) (NP (NP (CD 92.7) (NN %)) (PRN (-LRB- -LRB-) (NP (NP (NNP SE=85.8) (NN %)) (, ,) (NP (NNP SP=86.0) (NN %))) (-RRB- -RRB-))))) (. .))
(NP (NP (NNS Conclusions)) (: :) (S (NP (DT The) (JJ validated) (NN system)) (VP (VBZ performs) (ADVP (RB comparably) (PP (TO to) (NP (JJ human) (NNS experts)))) (PP (IN at) (NP (NP (JJ simultaneous) (NN detection)) (PP (IN of) (NP (NNP DR) (CC and) (NNP AMD))))))) (. .))
(S (NP (DT This)) (VP (VBZ shows) (SBAR (IN that) (S (NP (NNP DL) (NNS systems)) (VP (MD can) (VP (VP (VB facilitate) (NP (NP (NN access)) (PP (TO to) (NP (NP (VB joint) (NN screening)) (PP (IN of) (NP (NN eye) (NNS diseases))))))) (CC and) (VP (VB become) (NP (NP (DT a) (ADJP (JJ quick) (CC and) (JJ reliable)) (NN support)) (PP (IN for) (NP (JJ ophthalmological) (NNS experts)))))))))) (. .))
